Comerica Bank’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$43.2K Sell
2,650
-36
-1% -$544 ﹤0.01% 2904
2025
Q3
$31.4K Sell
2,686
-5,082
-65% -$66.3K ﹤0.01% 2978
2025
Q2
$90K Buy
7,768
+6,574
+551% +$59.9K ﹤0.01% 2628
2025
Q1
$10.4K Sell
1,194
-432
-27% -$5.45K ﹤0.01% 3163
2024
Q4
$23.3K Sell
1,626
-557
-26% -$8.79K ﹤0.01% 2992
2024
Q3
$49.3K Buy
2,183
+403
+23% +$8.33K ﹤0.01% 2801
2024
Q2
$34.6K Buy
1,780
+104
+6% +$2.72K ﹤0.01% 2857
2024
Q1
$62.9K Sell
1,676
-211
-11% -$9.27K ﹤0.01% 2691
2023
Q4
$106K Buy
1,887
+340
+22% +$14.8K ﹤0.01% 2480
2023
Q3
$63.8K Buy
+1,547
New +$80.5K ﹤0.01% 2628
2021
Q3
Sell
-2,364
Closed -$364K 2344
2021
Q2
$364K Buy
2,364
+606
+34% +$110K ﹤0.01% 2106
2021
Q1
$341K Sell
1,758
-194
-10% -$33.5K ﹤0.01% 2124
2020
Q4
$365K Sell
1,952
-181
-8% -$26.3K ﹤0.01% 2080
2020
Q3
$303K Buy
+2,133
New +$224K ﹤0.01% 2069

Other funds holding TXG

Comerica Bank's TXG Position: Q4 2025 in Review

Comerica Bank reduced its 10x Genomics (TXG) stake by 1.3% in Q4 2025, selling an estimated $544 and leaving 2,650 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2904.

Comerica Bank first reported a position in TXG in Q3 2020 and has held it in 14 quarters since. The position peaked at $365K in Q4 2020. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Comerica Bank held 2,650 shares of 10x Genomics worth $43.2K as of Q4 2025.
  • Comerica Bank sold 36 10x Genomics shares in Q4 2025, an estimated $544.
  • 10x Genomics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2904 holding.
  • Comerica Bank first reported a position in 10x Genomics in Q3 2020 and has held it in 14 quarters since.
  • Comerica Bank's 10x Genomics position peaked at $365K in Q4 2020.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.